EIA versus RIA in Detecting Carcinoembryonic Antigen Level of Patients with Metastatic Colorectal Cancer

Hepato-Gastroenterology

Volumn 51, Issue 55, 2004, Pages 136-141

  Wang, Wei Shu ^a   Lin, Jen Kou ^a,b   Lin, Tzu Chen ^a,b   Chiou, Tzeon Jye ^a   Liu, Jin Hwang ^a   Yen, Chueh Chuan ^a   Chen, Wei Shone ^a,b   Jiang, Jeng Kae ^a,b   Yang, Shung Haur ^a,b   Wang, Huann Sheng ^a,b   Chen, Po Min ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Carcinoembryonic antigen; Colorectal cancer; EIA; RIA

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

ANTIGEN DETECTION; ARTICLE; BENIGN TUMOR; BLOOD ANALYSIS; BLOOD SAMPLING; CANCER DIAGNOSIS; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC KIT; DIFFERENTIAL DIAGNOSIS; ENZYME IMMUNOASSAY; FEMALE; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SENSITIVITY AND SPECIFICITY;

ADULT; CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LIVER NEOPLASMS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RADIOIMMUNOASSAY; SENSITIVITY AND SPECIFICITY;

EID: 10744229739     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Gold P, Freedman SO: Specific carcinoembryonic antigens of the human digestive system. J Exp Med 1965; 122:467-481.
2. The American Society of Clinical Oncology: Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer. J Clin Oncol 1996; 14:2843-2877.
3. Wang WS, Lin JK, Chiou TJ, Liu JH, Fan FS, YEN CC, Lin TC, Jiang JK, Yang SH, Wang HS, Chen PM: Preoperative carcinoembryonic antigen level as an independent prognostic factor in colorectal cancer: Taiwan experience. Jpn J Clin Oncol 2000; 30:12-16.
4. Moertel CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA, Tangen C: An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer. JAMA 1993; 270:943-947.
5. Slentz K, Senagore A, Hibbert J, Mazier WP, Talbott TM: Can preoperative and postoperative CEA predict survival after colon cancer resection? Am Surg 1994; 60:528-531.
6. Wang WS, Lin JK, Lin TC, Chiou TJ, Liu JH, Fan FS, YEN CC, Chen WS, Jiang JK, Yang SH, Wang HS, Chen PM: Carcinoembryonic antigen in monitoring of response to systemic chemotherapy in patients with metastatic colorectal cancer. Int J Colorectal Dis 2001; 16:96-101.
7. Allen-Mersh TG, Kemeny N, Niedzwiecki D, Shurgot B, Daly JM: Significance of a fall in serum CEA concentration in patients treated with cytotoxic chemotherapy for disseminated colorectal cancer. Gut 1987; 28:1625-1629.
8. Petrelli N, Douglass HO, Herrera L, Russell D, Stablein DM, Bruckner HW, Mayer RJ, Schinella R, Green MD, Muggia FM: The modulation of fluorouracil with leucovorin in metastatic colorectal carcinoma: a prospective randomized phase III trial. J Clin Oncol 1989; 7:1419-1426.
9. Bedikian AY, Stroehlein J, Korioek J, Karlin D, Bodey GP: A comparative study of oral tegafur and intravenous 5-fluorouracil in patients with metastatic colorectal cancer. Am J Clin Oncol 1983; 6:181-186.
10. de Gramont A, Vignoud J, Tournigand C, Louvet C, Andre T, Varette C, Raymond E, Moreau S, Le Bail N, Krulik M: Oxaliplatin with high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer. Eur J Cancer 1997; 33:214-219.
11. Douillard JY, Cunningham D, Roth AD, Navarro M, James RD, Karasek P, Jandik P, Iveson T, Carmichael J, Alakl M, Gruia G, Awad L, Rougier P: Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomized trial. Lancet 2000; 355:1041-1047.
12. Bartko JJ: The intraclass correlation coefficient as a measure of reliability. Psychol Rep 1966; 19:3-11.
13. Krupey J, Gold P, Freedman SO: Physicochemical studies of the carcinoembryonic antigens of the human digestive system. J Exp Med 1968; 128:387-398.
14. Thomson DM, Krupey J, Freedman SO, Gold P: The radioimmunoassay of circulating carcinoembryonic antigen of the human digestive system. Proc Natl Acad Sci USA 1969; 64:161-167.
15. Martin EW, Cooperman M, King G, Rinker L, Carey LC, Minton JP: A retrospective and prospective study of serial CEA determinations in the early detection of recurrent colon cancer. Am J Surg 1979; 137:167-169.
16. Skarin AT, Delwiche R, Zamcheck N, Lokich JJ, Frei E 3rd: Carcinoembryonic antigen: clinical correlation with chemotherapy for metastatic gastrointestinal cancer. Cancer 1974; 33:1239-1245.
17. Harlozinska A, Rachel F, Gawlikowski W, Richter R, Kolodziej J: CEA and NCA levels in peripheral and tumor venous blood of patients with gastric and colonic carcinomas estimated by RIA and EIA methods. Eur J Surg Oncol 1991; 17:59-64.
18. Albert Z, Balbierz H, Breborowicz J, Harlozinska A, Lisowska E, Lucka B, Majewski P, Richter R, Russin K, Siuda A, Zawadzka H: Reagents for radioimmunological determination of carcinoembryonic antigen (CEA). Arch Immunol Ther Exp 1978; 26:227-229.
19. Orjasaeter H, Staab HJ, Heier HE, Hornung A, Kjorstad K, Luedin E, Rognum TO, Bell H: Comparison of a CEA-EIA assay based on monoclonal antibody with a CEA-RIA assay with polyclonal antiserum. NIPH Ann 1985; 8:13-26.
20. Thompson J, Zimmerman W: The carcinoembryonic antigen gene family: structure, expression and evolution. Tumor Biol 1988; 9:63-83.
21. Bormer OP: Major disagreements between immunoassays of carcinoembryonic antigen may be caused by nonspecific cross-reacting antigen 2 (NCA-2). Clin Chem 1991; 37:1736-1739.
22. Suzuki N, Kondo K, Tominaga S, Kuroki M, Matsuoka Y: Heterogeneity of circulating carcinoembryonic antigen analyzed by sandwich-enzyme immunoassays with different specificities. Cancer Res 1987; 47:4782-4787.